AVEO Oncology
AVEO
#7373
Rank
NZ$0.92 B
Marketcap
NZ$26.58
Share price
0.00%
Change (1 day)
190.99%
Change (1 year)

Market capitalization of AVEO Oncology (AVEO)

Last known market cap: NZ$0.92 Billion

On March 24, 2023 AVEO Oncology had a market cap of NZ$0.92 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AVEO Oncology from 2010 to 2023

End of year Market Cap

Year Marketcap Change
2023NZ$0.82 B0.73%
2022NZ$0.81 B246.82%
2021NZ$0.23 B2.45%
2020NZ$0.23 B54.54%
2019NZ$0.14 B-50.59%
2018NZ$0.30 B-35.09%
2017NZ$0.46 B685.96%
2016NZ$59.14 M-44.79%
2015NZ$0.10 B91.03%
2014NZ$56.07 M-51.4%
2013NZ$0.11 B-73.07%
2012NZ$0.42 B-55%
2011NZ$0.95 B41.11%
2010NZ$0.67 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Eli Lilly
LLY
NZ$1.909 T 206,504.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$342.75 B 36,987.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$56.52 B 6,016.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$117.59 B 12,624.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$208.17 B 22,425.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
NZ$0.39 B-57.09%๐Ÿ‡บ๐Ÿ‡ธ USA